Webflow Homepage
Veterinarians
Services For
Canine lymphoma & Leukemia
Personalized Prediction Profile
AI-Driven Drug Response Predictions
(Flow Cytometry + PARR included)
Drug Response Predictions
NEW
Personalize anticancer drug treatment decisions with confidence
Immunoprofile
Get accurate diagnostic support from the start (Flow Cytometry + PARR)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Multidrug Sensitivity Genotyping (MDR1)
Identify MDR1 carrier status with ease
Services For
FELINE lymphoma & Leukemia
Immunoprofile
Get accurate diagnostic support from the start (PARR + Flow Cytometry)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
for
veterinarians
Order Services via Vet Portal
Request Sample Reports
See what you will get when you order ImpriMed's services
Request Pricing
Become an ImpriMed Provider
Participate in Our Research
💖 Wall of Love: Customer Reviews
Veterinary Cancer Pioneers Podcast
Contact Us
Pet Parents
LEARN
How It Works
Dog Lymphoma 101
Cat Lymphoma 101
Blog
Content Library
Get Started
Find a Veterinary Oncologist
Talk to Your Veterinarian
Customer stories & Case Studies
ImpriMed Reviews
Discover what other pet parents are saying and how oncologists use ImpriMed's reports
Human Oncology
CRO
Company
Company
Our Science
About Us
Careers
Events
Press
Contact Us
Contact Us
Other Links
ImpriMed Korea
Pricing
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Find a Vet
Get Started
Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Press Releases
ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers
PR Underground
Learn More →
Press Releases
ImpriMed Raises $4M for Customized Cancer Treatments for Dogs
GlobeNewswire
Learn More →
Previous
